Dendreon: revenue forecast 2011-2014
Shown is a forecast for the revenue of biotech company Dendreon from 2011 to 2014.
Estimated revenue of biotech company Dendreon from 2011 to 2014 (in billion U.S. dollars)
* For commercial use only
Basic Account
For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
- Free Statistics
Based on your interests
Starter Account
For single users
$199 USD
per month, billed annually
1
- Free Statistics
- Premium Statistics
The statistic on this page is a Premium Statistic and is included in this account.
Professional Account
For teams of up to 5 people
$959 USD
per month, billed annually
1
- Free + Premium Statistics
- Reports
- Market Insights
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
Other statistics that may interest you Pharmaceutical industry in Southeast Asia
Overview
5
- Premium Statistic Pharmaceutical market: worldwide revenue 2001-2023
- Premium Statistic Regional pharmaceutical market revenue worldwide 2022
- Premium Statistic Global pharmaceutical market - revenue distribution 2010-2023, by region
- Premium Statistic World pharmaceutical market growth by region 2023-2027
- Premium Statistic Distribution of pharmaceutical R&D companies by region 2023 vs. 2024
SEA overview
4
OTC pharmaceuticals
4
International trade
3
Clinical trials
3
Consumer perspective
3
Further related statistics
10
- Expenditure worldwide on diabetes by market 2013-2018
- Merck & Co total assets 2009-2023
- Merck & Co - expenditure on research and development 2006-2023
- Annual revenue of Sinopharm 2010-2022
- Revenue of Sinopharm 2011-2022, by category
- Number of employees at Sinopharm 2011-2022
- M&A capacities - changes for the global pharma industry 2008-2015
- Medicinal market growth worldwide including rebates 2009-2018
- Global pharmaceutical pipeline by therapy area 2013-2017
- Merck & Co cash dividends declared 2006-2023
Further Content: You might find this interesting as well
Statistics
- Expenditure worldwide on diabetes by market 2013-2018
- Merck & Co total assets 2009-2023
- Merck & Co - expenditure on research and development 2006-2023
- Annual revenue of Sinopharm 2010-2022
- Revenue of Sinopharm 2011-2022, by category
- Number of employees at Sinopharm 2011-2022
- M&A capacities - changes for the global pharma industry 2008-2015
- Medicinal market growth worldwide including rebates 2009-2018
- Global pharmaceutical pipeline by therapy area 2013-2017
- Merck & Co cash dividends declared 2006-2023
* For commercial use only
Basic Account
For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
- Free Statistics
Based on your interests
Starter Account
For single users
$199 USD
per month, billed annually
1
- Free Statistics
- Premium Statistics
The statistic on this page is a Premium Statistic and is included in this account.
Professional Account
For teams of up to 5 people
$959 USD
per month, billed annually
1
- Free + Premium Statistics
- Reports
- Market Insights
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
Der Aktionär. (November 17, 2010). Estimated revenue of biotech company Dendreon from 2011 to 2014 (in billion U.S. dollars) [Graph]. In Statista. Retrieved November 13, 2024, from https://www-statista-com.ezproxy.canberra.edu.au/statistics/270555/forecast-for-revenue-of-dendreon/
Der Aktionär. "Estimated revenue of biotech company Dendreon from 2011 to 2014 (in billion U.S. dollars)." Chart. November 17, 2010. Statista. Accessed November 13, 2024. https://www-statista-com.ezproxy.canberra.edu.au/statistics/270555/forecast-for-revenue-of-dendreon/
Der Aktionär. (2010). Estimated revenue of biotech company Dendreon from 2011 to 2014 (in billion U.S. dollars). Statista. Statista Inc.. Accessed: November 13, 2024. https://www-statista-com.ezproxy.canberra.edu.au/statistics/270555/forecast-for-revenue-of-dendreon/
Der Aktionär. "Estimated Revenue of Biotech Company Dendreon from 2011 to 2014 (in Billion U.S. Dollars)." Statista, Statista Inc., 17 Nov 2010, https://www-statista-com.ezproxy.canberra.edu.au/statistics/270555/forecast-for-revenue-of-dendreon/
Der Aktionär, Estimated revenue of biotech company Dendreon from 2011 to 2014 (in billion U.S. dollars) Statista, https://www-statista-com.ezproxy.canberra.edu.au/statistics/270555/forecast-for-revenue-of-dendreon/ (last visited November 13, 2024)
Estimated revenue of biotech company Dendreon from 2011 to 2014 (in billion U.S. dollars) [Graph], Der Aktionär, November 17, 2010. [Online]. Available: https://www-statista-com.ezproxy.canberra.edu.au/statistics/270555/forecast-for-revenue-of-dendreon/